Asterias Biotherapeutics (AST) Shares Tick Higher on Positive Mention
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Asterias Biotherapeutics (NYSE: AST) shares are popping to session highs amid a positive mention today by CIRM. The article highlights the benefits of a stem cell clinical trial in helping a spinal cord injury patient regain mobility.
The stock is up over 5 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Asterias Announces Conference Call to Discuss 6-month Efficacy Data from AST-OPC1 SCiStar Study
- Stocks with Implied Volatility Movement
- Alaska Air (ALK) call put ratio 2 calls to 1 put into Q4
Create E-mail Alert Related CategoriesFDA, Momentum Movers, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!